SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-23-117185
Filing Date
2023-11-13
Accepted
2023-11-13 16:01:15
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-11-13

Document Format Files

Seq Description Document Type Size
1 ARS tm2325918d3_ars.pdf ARS 597749
  Complete submission text file 0001104659-23-117185.txt   824859
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38356 | Film No.: 231398422
SIC: 2834 Pharmaceutical Preparations